To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Select Committee
Little Heartbeats
PRT0082 - Preterm Birth

Written Evidence May. 14 2024

Inquiry: Preterm Birth
Inquiry Status: Closed
Committee: Preterm Birth Committee

Found: As a result, I was not given antibiotics, infection was missed, and I developed sepsis.


Written Question
Health: Technology
Tuesday 26th March 2024

Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the NHS is taking steps with (a) technology developers and (b) academia to help accelerate the introduction of innovative medical solutions.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.

In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.


Written Question
Health: Technology
Tuesday 26th March 2024

Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help encourage innovation in the development of healthcare technology for at home use.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.

In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.


Written Question
Sepsis: Mortality Rates
Monday 10th July 2023

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what was the incidence of sepsis in the UK in 2022; and what were the mortality rates for sepsis in (1) 2019, (2) 2020, (3) 2021, and (4) 2022.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

Information on the incidence of sepsis in the United Kingdom in 2022 has not been validated and cannot yet be published. Information on the mortality rates for sepsis is not held, however the Office for National Statistics (ONS) has published the number of death registrations where sepsis was mentioned anywhere on the death certificate in England and Wales between 2001 and 2021. The number of deaths registered where sepsis was mentioned anywhere on the death certificate in England and Wales was 21,458 for 2019, 19,324 for 2020, and 21,947 for 2021. ONS has not yet published the number of death registrations for sepsis for 2022.


Scottish Parliament Debate - Main Chamber
Complex Regional Pain Syndrome Awareness Month - Wed 20 Dec 2023

Mentions:
1: Mackay, Rona (SNP - Strathkelvin and Bearsden) One memorable petition sought to raise awareness of sepsis as a potentially fatal condition; it still - Speech Link


Select Committee
Roundtable transcript, Group 3, 30.01.24
PSN0033 - Expert Panel: Evaluation of Government’s progress on meeting patient safety recommendations

Written Evidence Mar. 19 2024

Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: My child also died of sepsis, not so long ago, just showing that very little has been learnt.


Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: National Patient Safety Alert: ​​Reducing risks for transfusion-associated circulatory overload​ ​(NatPSA/2024/004/MHRA​)
Document: TACO Chapter (PDF)

Found: Case 13c.1: An elderly man with renal failure An 82 year old man with type-2 diabetes, sepsis and acute


Written Question
Cancer and Sepsis: Rehabilitation
Tuesday 11th July 2023

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what funding they are allocating to rehabilitation for (1) sepsis survivors, and (2) cancer survivors; and whether there are any planned changes to that funding.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department does not hold figures on funding allocated to rehabilitation for specific diseases. People who have experienced sepsis and cancer have access to follow-up pathways with options for personalised healthcare to suit their individual needs, including a needs assessment, rehabilitation, and other services, such as physiotherapy, as deemed appropriate by their healthcare provider. NHS England is working closely with NHS@Home to ensure patients have the option to be monitored from the place they call home, including care homes, using virtual wards.


Scottish Parliament Debate - Main Chamber
Renfrewshire Health and Social Care Partnership - Tue 11 Jun 2024

Mentions:
1: Bibby, Neil (Lab - West Scotland) Montrose care home after facing the devastation of having all four of his limbs amputated as a result of sepsis - Speech Link


Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Jun. 10 2024

Source Page: Class 4 Medicines Defect Information: Dawa Limited, Paracetamol 500mg, 1000mg Film-Coated Tablets, EL (24)A/21
Document: Class 4 Medicines Defect Information: Dawa Limited, Paracetamol 500mg, 1000mg Film-Coated Tablets, EL (24)A/21 (PDF)

Found: that must have urgent treatment and which may occur particularly in case of severe renal impairment, sepsis